ilmscore | Prediction Details
"From a guidance point of view, the management says that in FI25 they will deliver high tens revenue growth along with a margin expansion of 100 to 150 basis points over FI2."
By Groww | December 4, 2024 | Pending
From video
How to pick stocks for SIP? (with examples) 00:10:09 - 00:10:17
Interpreted Prediction
Zydis Life Sciences management predicts high double-digit revenue growth and a margin expansion of 100 to 150 basis points in FY25 compared to FY2.

Prediction Details

Topic
Zydis Life Sciences revenue growth and margin expansion

Comments

0 comments

Be the first to share your thoughts.

Like this prediction?

Join to make your opinion count.